JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.65B |
| 2 |
Microsoft
MSFT
|
+$2.99B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.57B |
| 5 |
ServiceNow
NOW
|
+$1.33B |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.4B |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.57B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$2.55B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.15B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.56B |
Sector Composition
| 1 | Technology | 21.83% |
| 2 | Healthcare | 10.29% |
| 3 | Financials | 9.88% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
MidWestOne Financial Group
MOFG
$618M
| $1.07M | ﹤0.01% |
39,660
+10,399
| +36% | +$280K |
|
3302
Core Laboratories
CLB
$595M
| $1.07M | ﹤0.01% |
60,356
-250
| -0.4% | -$4.42K |
|
3303
Sonic Automotive
SAH
$2.73B
| $1.07M | ﹤0.01% |
18,947
-693
| -4% | -$39K |
|
|
ZLS
3304
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
| $1.06M | ﹤0.01% |
99,999
-1
| -0% | -$11 |
|
3305
Brookfield Infrastructure Partners
BIP
$14.4B
| $1.06M | ﹤0.01% |
33,765
+24,482
| +264% | +$771K |
|
3306
SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.49B
| $1.06M | ﹤0.01% |
14,476
+1,226
| +9% | +$90K |
|
|
NVTA
3307
DELISTED
Invitae Corporation
NVTA
| $1.06M | ﹤0.01% |
1,690,275
+17,320
| +1% | +$10.9K |
|
3308
Amylyx Pharmaceuticals
AMLX
$1.41B
| $1.06M | ﹤0.01% |
71,888
-19,077
| -21% | -$281K |
|
|
PEGR
3309
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $1.06M | ﹤0.01% |
99,997
-80,003
| -44% | -$846K |
|
3310
Accel Entertainment
ACEL
$939M
| $1.06M | ﹤0.01% |
102,789
+63,169
| +159% | +$649K |
|
3311
Planet Labs
PL
$3.27B
| $1.05M | ﹤0.01% |
426,783
+135,605
| +47% | +$335K |
|
|
CATC
3312
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.05M | ﹤0.01% |
15,103
+9,902
| +190% | +$687K |
|
3313
Bristow Group
VTOL
$1.11B
| $1.05M | ﹤0.01% |
37,070
+9,017
| +32% | +$255K |
|
3314
Ternium
TX
$6.9B
| $1.05M | ﹤0.01% |
24,656
-70
| -0.3% | -$2.97K |
|
3315
TORM
TRMD
$2.27B
| $1.05M | ﹤0.01% |
+34,427
| New | +$1.05M |
|
|
SVM
3316
Silvercorp Metals
SVM
$1.13B
| $1.04M | ﹤0.01% |
396,919
-94,131
| -19% | -$248K |
|
3317
Takeda Pharmaceutical
TAK
$47.4B
| $1.04M | ﹤0.01% |
73,080
-219,052
| -75% | -$3.13M |
|
3318
Allient
ALNT
$810M
| $1.04M | ﹤0.01% |
34,498
-94,667
| -73% | -$2.86M |
|
3319
Neumora Therapeutics
NMRA
$254M
| $1.04M | ﹤0.01% |
+61,117
| New | +$1.04M |
|
3320
VanEck Morningstar International Moat ETF
MOTI
$195M
| $1.03M | ﹤0.01% |
33,078
+5,174
| +19% | +$161K |
|
3321
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$379M
| $1.02M | ﹤0.01% |
35,055
-17,510
| -33% | -$511K |
|
3322
Karyopharm Therapeutics
KPTI
$49.7M
| $1.02M | ﹤0.01% |
78,741
+2,666
| +4% | +$34.6K |
|
3323
Altimmune
ALT
$342M
| $1.02M | ﹤0.01% |
90,795
+30,467
| +51% | +$343K |
|
3324
Cartesian Therapeutics
RNAC
$268M
| $1.02M | ﹤0.01% |
49,360
-674
| -1% | -$13.9K |
|
|
INVX
3325
Innovex International, Inc.
INVX
$1.18B
| $1.02M | ﹤0.01% |
43,861
-15,131
| -26% | -$352K |
|